These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19935782)

  • 1. Regulatory T cells and immune tolerance to coagulation factor IX in the context of intramuscular AAV1 gene transfer.
    Kelly M; Bharadwaj AS; Tacke F; Chao H
    Mol Ther; 2010 Feb; 18(2):361-9. PubMed ID: 19935782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune tolerance to FIX following muscular AAV gene transfer is AAV-dose/FIX-level dependent.
    Kelly ME; Zhuo J; Bharadwaj AS; Chao H
    Mol Ther; 2009 May; 17(5):857-63. PubMed ID: 19240690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.
    Cohn EF; Zhuo J; Kelly ME; Chao HJ
    J Thromb Haemost; 2007 Jun; 5(6):1227-36. PubMed ID: 17362228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.
    Bharadwaj AS; Kelly M; Kim D; Chao H
    Blood; 2010 Jan; 115(3):500-9. PubMed ID: 19965663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.
    Cao O; Dobrzynski E; Wang L; Nayak S; Mingle B; Terhorst C; Herzog RW
    Blood; 2007 Aug; 110(4):1132-40. PubMed ID: 17438084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.
    Cooper M; Nayak S; Hoffman BE; Terhorst C; Cao O; Herzog RW
    Hum Gene Ther; 2009 Jul; 20(7):767-76. PubMed ID: 19309290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX.
    Shi Y; Falahati R; Zhang J; Flebbe-Rehwaldt L; Gaensler KM
    Gene Ther; 2013 Oct; 20(10):987-96. PubMed ID: 23759700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of regulatory T cells in gene transfer.
    Cao O; Furlan-Freguia C; Arruda VR; Herzog RW
    Curr Gene Ther; 2007 Oct; 7(5):381-90. PubMed ID: 17979684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for contribution of CD4+ CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector delivery.
    Nivsarkar MS; Buckley SM; Parker AL; Perocheau D; McKay TR; Rahim AA; Howe SJ; Waddington SN
    J Immunol Res; 2015; 2015():397879. PubMed ID: 25759840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer.
    Herzog RW; Cooper M; Perrin GQ; Biswas M; Martino AT; Morel L; Terhorst C; Hoffman BE
    Cell Immunol; 2019 Aug; 342():103682. PubMed ID: 28888664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.
    Mingozzi F; Liu YL; Dobrzynski E; Kaufhold A; Liu JH; Wang Y; Arruda VR; High KA; Herzog RW
    J Clin Invest; 2003 May; 111(9):1347-56. PubMed ID: 12727926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle as a target for supplementary factor IX gene transfer.
    Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
    Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.
    Dobrzynski E; Fitzgerald JC; Cao O; Mingozzi F; Wang L; Herzog RW
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4592-7. PubMed ID: 16537361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors.
    Chao H; Monahan PE; Liu Y; Samulski RJ; Walsh CE
    Mol Ther; 2001 Sep; 4(3):217-22. PubMed ID: 11545612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity of immune responses to AAV transgene products - Example of factor IX.
    Herzog RW
    Cell Immunol; 2019 Aug; 342():103658. PubMed ID: 28645365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
    Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
    Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs.
    Zhang J; Xu L; Haskins ME; Parker Ponder K
    Blood; 2004 Jan; 103(1):143-51. PubMed ID: 12969967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.
    Ge Y; Powell S; Van Roey M; McArthur JG
    Blood; 2001 Jun; 97(12):3733-7. PubMed ID: 11389010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.
    Sabatino DE; Mackenzie TC; Peranteau W; Edmonson S; Campagnoli C; Liu YL; Flake AW; High KA
    Mol Ther; 2007 Sep; 15(9):1677-85. PubMed ID: 17565352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
    Le Quellec S; Dane A; Enjolras N; McIntosh J; Rosales C; Negrier C; Nathwani A
    Haemophilia; 2019 Jan; 25(1):e11-e18. PubMed ID: 30520547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.